Latest News about NVO
Recent news which mentions NVO
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
April 15, 2025
From Benzinga
From Motley Fool
Recent Filing Shows That Rep. Scott Franklin Bought Over $16K Worth of Novo Nordisk Stock
April 14, 2025
From Benzinga
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
From Benzinga
5 Top Growth Stocks to Buy in the Stock Market Sell-Off
April 09, 2025
From Motley Fool
Trump Administration Reverses Biden's Plan For Medicare Coverage Of Obesity Drugs Like Ozempic And Zepbound
April 08, 2025
From Benzinga
Eli Lilly And Novo Nordisk Could Face Policy Shifts As FDA Oversight, Tariff Risks Mount
April 07, 2025
From Benzinga
Why Hims & Hers Health Stock Couldn't Beat the Market Today
April 02, 2025
From Motley Fool
Novo Nordisk Stakeholder Reports $9 Billion In Income Due To Robust Weight Loss Drug Sales
April 02, 2025
From Benzinga
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 01, 2025
From Benzinga
From Benzinga
US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst
March 31, 2025
From Benzinga
While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%
March 31, 2025
From Benzinga
Is Hims & Hers Stock Too Cheap to Pass Up?
March 29, 2025
From Motley Fool
Benzinga Bulls And Bears: Chevron, Microsoft, Nike — And Tariffs Have Automotive Sector Reeling
March 29, 2025
From Benzinga
Deal Dispatch: Bezos-Backed Crop Company Wilts, Tech Startup Nabs Napster For $207 Million
March 28, 2025
From Benzinga
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
March 28, 2025
From Benzinga
From Motley Fool
Why Novo Nordisk Stock Dipped on Thursday
March 27, 2025
From Motley Fool
1 Growth Stock Down 40% to Buy and Hold Forever
March 27, 2025
From Motley Fool
From Benzinga
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
March 26, 2025
From Benzinga
From Benzinga
From Motley Fool
Motley Fool 2025 March Market Cap Showdown Championship
March 24, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
